Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Downgrades Applied Molecular to Hold

Jefferies Downgrades Applied Molecular to Hold

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

Barclays Maintains Equal-Weight on Lennox International, Lowers Price Target to $230

By Benzinga Newsdesk

July 8, 8:14 AM

Barclays analyst Julian Mitchell maintains Lennox International (NYSE:LII) with a Equal-Weight and lowers the price target from $240 to $230.

LII

White House Expresses Concern Over $14.1B US Steel Deal With Japan’s Nippon Steel

By Benzinga Neuro

December 22, 9:12 AM

The deal revealed earlier this week, is under "serious scrutiny", as per a statement issued on Thursday by the Biden Administration's leading economic adviser, Lael Brainard.

NPSCY

GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings

By Priya Nigam

April 10, 12:10 PM

GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.

GDRX

JD.Com Gears Up For Significant Pay Increases Despite Volatility In Chinese Consumer Trends

By Benzinga Neuro

December 28, 4:49 AM

The salary hike could be seen as part of these transformative changes aimed at boosting employee morale and productivity

BABA

Jefferies Downgrades Applied Molecular to Hold

Related Posts

Barclays Maintains Equal-Weight on Lennox International, Lowers Price Target to $230

White House Expresses Concern Over $14.1B US Steel Deal With Japan’s Nippon Steel

GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings

JD.Com Gears Up For Significant Pay Increases Despite Volatility In Chinese Consumer Trends